These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 580921)

  • 1. [Cellular immunity in 18 cirrhotic African carriers of hepatitis B virus surface antigen (HBsAg)].
    Sankale M; Agbetra M
    Bull Soc Pathol Exot Filiales; 1977; 70(4):435-7. PubMed ID: 580921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular immunity in hepatitis type B--mixed lymphocyte culture of peripheral blood from HBs-Ag carriers (author's transl)].
    Nozaki H; Tsuji T; Nagashima H
    Rinsho Byori; 1978 Feb; 26(2):153-8. PubMed ID: 147352
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 7. [T- and B-lymphocytes, M, A and G immunoglobulins in viral hepatitis, liver cirrhosis and HBs-Ag carrier state].
    Belozerov ES; Sagandikov BB; Shabalin VV
    Klin Med (Mosk); 1979 Mar; 57(3):63-5. PubMed ID: 312361
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
    Sylvan SP; Hellström UB; Lundbergh PR
    Clin Exp Immunol; 1985 Nov; 62(2):288-95. PubMed ID: 3878745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological study of carriers of Australia antigen (HBsAg)].
    Rizzetto M; Verme G
    Minerva Med; 1978 Aug; 69(38):2569-72. PubMed ID: 714258
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity in the evolution of acute and chronic HBsAg hepatitis.
    Scalise G; Mura MS; Piersimoni C
    Ann Sclavo; 1981; 23(1):92-105. PubMed ID: 7294920
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of the skin reaction to DNCB and to PHA during a course of acute viral HBs Ag positive and negative hepatitis and in carriers of HBs Ag].
    Lanzalene CM; D'Amate C; Cirelli A
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1638-41. PubMed ID: 1230164
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
    Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
    Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HBsAg in pregnancy. Effect on humoral and cellular immunity of the newborn infant].
    De Martino M; Pierro U; Genazzani A; Varone D; Vierucci A
    Minerva Pediatr; 1979 Sep; 31(17):1239-46. PubMed ID: 317128
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity in response to HBs antigen.
    Szkaradkiewicz A; Kiczka W
    Z Immunitatsforsch Immunobiol; 1978 Sep; 154(5):463-70. PubMed ID: 726550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte stimulation in hepatitis B infections.
    Tong MJ; Wallace AM; Peters RL; Reynolds TB
    N Engl J Med; 1975 Aug; 293(7):318-22. PubMed ID: 1152922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
    Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
    Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of HBs Ag and anti-HBs measured by countercurrent discontinuous immunoelectrophoresis (C-IEP)].
    Duca M; Colev A; Caraman D; Vîrnă G; Marinescu C
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(1):59-63. PubMed ID: 866839
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference of subtypes of hepatitis B surface antigen between asymptomatic carriers and patients with chronic liver diseases.
    Nakamura S; Takezawa Y; Maeda T
    Tohoku J Exp Med; 1980 Nov; 132(3):367-8. PubMed ID: 6162245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.